APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Companion Animal Anti-infectives

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Companion Animal Anti-infectives Market Outlook and Growth Opportunities 2026

Report ID 173979920422 December 2025193 pages

Choose your research edition.

Industry ResearchCompanion Animal Anti-infectives Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Companion Animal Anti-infectives Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Companion Animal Anti-infectives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Companion Animal Anti-infectives Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Companion Animal Anti-infectives Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Companion Animal Anti-infectives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Companion Animal Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Companion Animal Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Companion Animal Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Companion Animal Anti-infectives market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Companion Animal Anti-infectives market include Bimeda Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Chanelle, Elanco, Vetoquinol, Virbac, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Companion Animal Anti-infectives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Companion Animal Anti-infectives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Companion Animal Anti-infectives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Companion Animal Anti-infectives market size, projected growth trends, production technologies, key applications, and end-use industries.

Companion Animal Anti-infectives Segment by Company

Bimeda Animal Health

Boehringer Ingelheim

Ceva Sante Animale

Chanelle

Elanco

Vetoquinol

Virbac

Bayer

Merck

Zoetis

Companion Animal Anti-infectives Segment by Type

Injection

Unguent

Companion Animal Anti-infectives Segment by Application

Dogs

Cats

Other

Companion Animal Anti-infectives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Companion Animal Anti-infectives status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Companion Animal Anti-infectives market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Companion Animal Anti-infectives significant trends, drivers, influence factors in global and regions.

6. To analyze Companion Animal Anti-infectives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Anti-infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Anti-infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Anti-infectives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Companion Animal Anti-infectives market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Companion Animal Anti-infectives industry.

Chapter 3: Detailed analysis of Companion Animal Anti-infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Companion Animal Anti-infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Companion Animal Anti-infectives in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Companion Animal Anti-infectives Industry Trends Table 2. Companion Animal Anti-infectives Industry Drivers Table 3. Companion Animal Anti-infectives Industry Opportunities and Challenges Table 4. Companion Animal Anti-infectives Industry Restraints Table 5. Global Companion Animal Anti-infectives Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Companion Animal Anti-infectives Revenue Share by Company (2021-2026) Table 7. Global Companion Animal Anti-infectives Sales Volume by Company (k units) & (2021-2026) Table 8. Global Companion Animal Anti-infectives Sales Volume Share by Company (2021-2026) Table 9. Global Companion Animal Anti-infectives Average Price (US$/unit) of Company (2021-2026) Table 10. Global Companion Animal Anti-infectives Company Ranking, (2024-2026) & (USD Million) Table 11. Global Companion Animal Anti-infectives Key Company Manufacturing Base & Headquarters Table 12. Global Companion Animal Anti-infectives Company, Product Type & Application Table 13. Global Companion Animal Anti-infectives Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Companion Animal Anti-infectives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Unguent Table 19. Global Companion Animal Anti-infectives Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Companion Animal Anti-infectives Sales Volume by Type (2021-2026) & (k units) Table 21. Global Companion Animal Anti-infectives Sales Volume by Type (2027-2032) & (k units) Table 22. Global Companion Animal Anti-infectives Sales Volume Share by Type (2021-2026) Table 23. Global Companion Animal Anti-infectives Sales Volume Share by Type (2027-2032) Table 24. Global Companion Animal Anti-infectives Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Companion Animal Anti-infectives Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Companion Animal Anti-infectives Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Companion Animal Anti-infectives Sales Value Share by Type (2021-2026) Table 28. Global Companion Animal Anti-infectives Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Dogs Table 30. Significant Companies of Cats Table 31. Significant Companies of Other Table 32. Global Companion Animal Anti-infectives Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Companion Animal Anti-infectives Sales Volume by Application (2021-2026) & (k units) Table 34. Global Companion Animal Anti-infectives Sales Volume by Application (2027-2032) & (k units) Table 35. Global Companion Animal Anti-infectives Sales Volume Share by Application (2021-2026) Table 36. Global Companion Animal Anti-infectives Sales Volume Share by Application (2027-2032) Table 37. Global Companion Animal Anti-infectives Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Companion Animal Anti-infectives Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Companion Animal Anti-infectives Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Companion Animal Anti-infectives Sales Value Share by Application (2021-2026) Table 41. Global Companion Animal Anti-infectives Sales Value Share by Application (2027-2032) Table 42. Global Companion Animal Anti-infectives Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Companion Animal Anti-infectives Sales by Region (2021-2026) & (k units) Table 44. Global Companion Animal Anti-infectives Sales Market Share by Region (2021-2026) Table 45. Global Companion Animal Anti-infectives Sales by Region (2027-2032) & (k units) Table 46. Global Companion Animal Anti-infectives Sales Market Share by Region (2027-2032) Table 47. Global Companion Animal Anti-infectives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Companion Animal Anti-infectives Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Companion Animal Anti-infectives Sales Value Share by Region (2021-2026) Table 50. Global Companion Animal Anti-infectives Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Companion Animal Anti-infectives Sales Value Share by Region (2027-2032) Table 52. Global Companion Animal Anti-infectives Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Companion Animal Anti-infectives Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Companion Animal Anti-infectives Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Companion Animal Anti-infectives Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Companion Animal Anti-infectives Sales by Country (2021-2026) & (k units) Table 57. Global Companion Animal Anti-infectives Sales Market Share by Country (2021-2026) Table 58. Global Companion Animal Anti-infectives Sales by Country (2027-2032) & (k units) Table 59. Global Companion Animal Anti-infectives Sales Market Share by Country (2027-2032) Table 60. Global Companion Animal Anti-infectives Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Companion Animal Anti-infectives Sales Value Market Share by Country (2021-2026) Table 62. Global Companion Animal Anti-infectives Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Companion Animal Anti-infectives Sales Value Market Share by Country (2027-2032) Table 64. Bimeda Animal Health Company Information Table 65. Bimeda Animal Health Business Overview Table 66. Bimeda Animal Health Companion Animal Anti-infectives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Bimeda Animal Health Companion Animal Anti-infectives Product Portfolio Table 68. Bimeda Animal Health Recent Development Table 69. Boehringer Ingelheim Company Information Table 70. Boehringer Ingelheim Business Overview Table 71. Boehringer Ingelheim Companion Animal Anti-infectives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Boehringer Ingelheim Companion Animal Anti-infectives Product Portfolio Table 73. Boehringer Ingelheim Recent Development Table 74. Ceva Sante Animale Company Information Table 75. Ceva Sante Animale Business Overview Table 76. Ceva Sante Animale Companion Animal Anti-infectives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Ceva Sante Animale Companion Animal Anti-infectives Product Portfolio Table 78. Ceva Sante Animale Recent Development Table 79. Chanelle Company Information Table 80. Chanelle Business Overview Table 81. Chanelle Companion Animal Anti-infectives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Chanelle Companion Animal Anti-infectives Product Portfolio Table 83. Chanelle Recent Development Table 84. Elanco Company Information Table 85. Elanco Business Overview Table 86. Elanco Companion Animal Anti-infectives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Elanco Companion Animal Anti-infectives Product Portfolio Table 88. Elanco Recent Development Table 89. Vetoquinol Company Information Table 90. Vetoquinol Business Overview Table 91. Vetoquinol Companion Animal Anti-infectives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Vetoquinol Companion Animal Anti-infectives Product Portfolio Table 93. Vetoquinol Recent Development Table 94. Virbac Company Information Table 95. Virbac Business Overview Table 96. Virbac Companion Animal Anti-infectives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Virbac Companion Animal Anti-infectives Product Portfolio Table 98. Virbac Recent Development Table 99. Bayer Company Information Table 100. Bayer Business Overview Table 101. Bayer Companion Animal Anti-infectives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Bayer Companion Animal Anti-infectives Product Portfolio Table 103. Bayer Recent Development Table 104. Merck Company Information Table 105. Merck Business Overview Table 106. Merck Companion Animal Anti-infectives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Merck Companion Animal Anti-infectives Product Portfolio Table 108. Merck Recent Development Table 109. Zoetis Company Information Table 110. Zoetis Business Overview Table 111. Zoetis Companion Animal Anti-infectives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Zoetis Companion Animal Anti-infectives Product Portfolio Table 113. Zoetis Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Companion Animal Anti-infectives Distributors List Table 117. Companion Animal Anti-infectives Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Companion Animal Anti-infectives Product Image Figure 2. Global Companion Animal Anti-infectives Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Companion Animal Anti-infectives Sales Value (2021-2032) & (US$ Million) Figure 4. Global Companion Animal Anti-infectives Sales (2021-2032) & (k units) Figure 5. Global Companion Animal Anti-infectives Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Companion Animal Anti-infectives Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Unguent Image Figure 11. Global Companion Animal Anti-infectives Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Companion Animal Anti-infectives Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Companion Animal Anti-infectives Sales Volume Share by Type (2021-2032) Figure 14. Global Companion Animal Anti-infectives Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Companion Animal Anti-infectives Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Companion Animal Anti-infectives Sales Value Share by Type (2021-2032) Figure 17. Dogs Image Figure 18. Cats Image Figure 19. Other Image Figure 20. Global Companion Animal Anti-infectives Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Companion Animal Anti-infectives Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Companion Animal Anti-infectives Sales Volume Share by Application (2021-2032) Figure 23. Global Companion Animal Anti-infectives Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Companion Animal Anti-infectives Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Companion Animal Anti-infectives Sales Value Share by Application (2021-2032) Figure 26. Global Companion Animal Anti-infectives Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Companion Animal Anti-infectives Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Companion Animal Anti-infectives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Companion Animal Anti-infectives Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Companion Animal Anti-infectives Sales Value (2021-2032) & (US$ Million) Figure 31. North America Companion Animal Anti-infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Companion Animal Anti-infectives Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Companion Animal Anti-infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Companion Animal Anti-infectives Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Companion Animal Anti-infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Companion Animal Anti-infectives Sales Value (2021-2032) & (US$ Million) Figure 37. South America Companion Animal Anti-infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Companion Animal Anti-infectives Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Companion Animal Anti-infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Companion Animal Anti-infectives Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Companion Animal Anti-infectives Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Unguent
Applications
  • Dogs
  • Cats
  • Other
Companies covered
  • Bimeda Animal Health
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Chanelle
  • Elanco
  • Vetoquinol
  • Virbac
  • Bayer
  • Merck
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Companion Animal Anti-infectives Sales Value (2021-2032)
  4. 1.2.2 Global Companion Animal Anti-infectives Sales Volume (2021-2032)
  5. 1.2.3 Global Companion Animal Anti-infectives Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Companion Animal Anti-infectives Market Dynamics
  1. 2.1 Companion Animal Anti-infectives Industry Trends
  2. 2.2 Companion Animal Anti-infectives Industry Drivers
  3. 2.3 Companion Animal Anti-infectives Industry Opportunities and Challenges
  4. 2.4 Companion Animal Anti-infectives Industry Restraints
3 Companion Animal Anti-infectives Market by Company
  1. 3.1 Global Companion Animal Anti-infectives Company Revenue Ranking in 2025
  2. 3.2 Global Companion Animal Anti-infectives Revenue by Company (2021-2026)
  3. 3.3 Global Companion Animal Anti-infectives Sales Volume by Company (2021-2026)
  4. 3.4 Global Companion Animal Anti-infectives Average Price by Company (2021-2026)
  5. 3.5 Global Companion Animal Anti-infectives Company Ranking (2024-2026)
  6. 3.6 Global Companion Animal Anti-infectives Company Manufacturing Base and Headquarters
  7. 3.7 Global Companion Animal Anti-infectives Company Product Type and Application
  8. 3.8 Global Companion Animal Anti-infectives Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Companion Animal Anti-infectives Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Companion Animal Anti-infectives Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Companion Animal Anti-infectives Market by Type
  1. 4.1 Companion Animal Anti-infectives Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Unguent
  4. 4.2 Global Companion Animal Anti-infectives Sales Volume by Type
  5. 4.2.1 Global Companion Animal Anti-infectives Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Companion Animal Anti-infectives Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Companion Animal Anti-infectives Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Companion Animal Anti-infectives Sales Value by Type
  9. 4.3.1 Global Companion Animal Anti-infectives Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Companion Animal Anti-infectives Sales Value by Type (2021-2032)
  11. 4.3.3 Global Companion Animal Anti-infectives Sales Value Share by Type (2021-2032)
5 Companion Animal Anti-infectives Market by Application
  1. 5.1 Companion Animal Anti-infectives Application Introduction
  2. 5.1.1 Dogs
  3. 5.1.2 Cats
  4. 5.1.3 Other
  5. 5.2 Global Companion Animal Anti-infectives Sales Volume by Application
  6. 5.2.1 Global Companion Animal Anti-infectives Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Companion Animal Anti-infectives Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Companion Animal Anti-infectives Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Companion Animal Anti-infectives Sales Value by Application
  10. 5.3.1 Global Companion Animal Anti-infectives Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Companion Animal Anti-infectives Sales Value by Application (2021-2032)
  12. 5.3.3 Global Companion Animal Anti-infectives Sales Value Share by Application (2021-2032)
6 Companion Animal Anti-infectives Regional Sales and Value Analysis
  1. 6.1 Global Companion Animal Anti-infectives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Companion Animal Anti-infectives Sales by Region (2021-2032)
  3. 6.2.1 Global Companion Animal Anti-infectives Sales by Region: 2021-2026
  4. 6.2.2 Global Companion Animal Anti-infectives Sales by Region (2027-2032)
  5. 6.3 Global Companion Animal Anti-infectives Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Companion Animal Anti-infectives Sales Value by Region (2021-2032)
  7. 6.4.1 Global Companion Animal Anti-infectives Sales Value by Region: 2021-2026
  8. 6.4.2 Global Companion Animal Anti-infectives Sales Value by Region (2027-2032)
  9. 6.5 Global Companion Animal Anti-infectives Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Companion Animal Anti-infectives Sales Value (2021-2032)
  12. 6.6.2 North America Companion Animal Anti-infectives Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Companion Animal Anti-infectives Sales Value (2021-2032)
  15. 6.7.2 Europe Companion Animal Anti-infectives Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Companion Animal Anti-infectives Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Companion Animal Anti-infectives Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Companion Animal Anti-infectives Sales Value (2021-2032)
  21. 6.9.2 South America Companion Animal Anti-infectives Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Companion Animal Anti-infectives Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Companion Animal Anti-infectives Sales Value Share by Country, 2025 VS 2032
7 Companion Animal Anti-infectives Country-level Sales and Value Analysis
  1. 7.1 Global Companion Animal Anti-infectives Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Companion Animal Anti-infectives Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Companion Animal Anti-infectives Sales by Country (2021-2032)
  4. 7.3.1 Global Companion Animal Anti-infectives Sales by Country (2021-2026)
  5. 7.3.2 Global Companion Animal Anti-infectives Sales by Country (2027-2032)
  6. 7.4 Global Companion Animal Anti-infectives Sales Value by Country (2021-2032)
  7. 7.4.1 Global Companion Animal Anti-infectives Sales Value by Country (2021-2026)
  8. 7.4.2 Global Companion Animal Anti-infectives Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Companion Animal Anti-infectives Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Companion Animal Anti-infectives Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Companion Animal Anti-infectives Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bimeda Animal Health
  2. 8.1.1 Bimeda Animal Health Company Information
  3. 8.1.2 Bimeda Animal Health Business Overview
  4. 8.1.3 Bimeda Animal Health Companion Animal Anti-infectives Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bimeda Animal Health Companion Animal Anti-infectives Product Portfolio
  6. 8.1.5 Bimeda Animal Health Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Companion Animal Anti-infectives Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Companion Animal Anti-infectives Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Ceva Sante Animale
  14. 8.3.1 Ceva Sante Animale Company Information
  15. 8.3.2 Ceva Sante Animale Business Overview
  16. 8.3.3 Ceva Sante Animale Companion Animal Anti-infectives Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ceva Sante Animale Companion Animal Anti-infectives Product Portfolio
  18. 8.3.5 Ceva Sante Animale Recent Developments
  19. 8.4 Chanelle
  20. 8.4.1 Chanelle Company Information
  21. 8.4.2 Chanelle Business Overview
  22. 8.4.3 Chanelle Companion Animal Anti-infectives Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Chanelle Companion Animal Anti-infectives Product Portfolio
  24. 8.4.5 Chanelle Recent Developments
  25. 8.5 Elanco
  26. 8.5.1 Elanco Company Information
  27. 8.5.2 Elanco Business Overview
  28. 8.5.3 Elanco Companion Animal Anti-infectives Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Elanco Companion Animal Anti-infectives Product Portfolio
  30. 8.5.5 Elanco Recent Developments
  31. 8.6 Vetoquinol
  32. 8.6.1 Vetoquinol Company Information
  33. 8.6.2 Vetoquinol Business Overview
  34. 8.6.3 Vetoquinol Companion Animal Anti-infectives Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Vetoquinol Companion Animal Anti-infectives Product Portfolio
  36. 8.6.5 Vetoquinol Recent Developments
  37. 8.7 Virbac
  38. 8.7.1 Virbac Company Information
  39. 8.7.2 Virbac Business Overview
  40. 8.7.3 Virbac Companion Animal Anti-infectives Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Virbac Companion Animal Anti-infectives Product Portfolio
  42. 8.7.5 Virbac Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Companion Animal Anti-infectives Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Companion Animal Anti-infectives Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Companion Animal Anti-infectives Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merck Companion Animal Anti-infectives Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Zoetis
  56. 8.10.1 Zoetis Company Information
  57. 8.10.2 Zoetis Business Overview
  58. 8.10.3 Zoetis Companion Animal Anti-infectives Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Zoetis Companion Animal Anti-infectives Product Portfolio
  60. 8.10.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Companion Animal Anti-infectives Value Chain Analysis
  2. 9.1.1 Companion Animal Anti-infectives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Companion Animal Anti-infectives Sales Mode & Process
  6. 9.2 Companion Animal Anti-infectives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Companion Animal Anti-infectives Distributors
  9. 9.2.3 Companion Animal Anti-infectives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst